South Korea Reports First Tamiflu-resistant Death

A South Korean infant infected with swine flu has died of pneumonia and respiratory failure after showing no response to the anti-viral drug Tamiflu, officials said Thursday.

The one-year-old girl died on December 1 in hospital, the health ministry said, adding that health officials discovered a strain of the (A)H1N1 virus resistant to Tamiflu in her body.

Experts Say Tamiflu Must be Administered Within Two Days
With the number of swine flu cases on the rise, experts are debating when exactly Tamiflu must be administered to get a proper response.

"It marked the first such fatality at home, but we need consultations with the (World Health Organisation) to see if it was the world's first such case," Chung Chan-Woo, an official at the ministry's swine flu centre, told AFP.

The girl was hospitalised on November 14 for high fever and coughs but her condition continued to deteriorate despite double doses of Tamiflu, he said.

The girl was too young to be given another anti-viral drug, Relenza, which is approved for treatment only in children who are seven years and older, he said.

Tamiflu Effective For High Risk Swine Flu Cases: WHO
The World Health Organisation on Friday stood by its advice on the use of Tamiflu in high risk swine flu patients, insisting that it was effective in those cases.

South Korea has reported two other cases of Tamiflu-resistant patients. Its death toll from swine flu has reached 118.

Source-AFP
SRM

Experts Question the Effectiveness of Tamiflu: Report
Experts question the effectiveness of antiviral drug Tamiflu commonly used against the swine flu virus spreading across the globe, according to a study reported in Britain Tuesday.

First Tamiflu-resistant Swine Flu Case Reported in South Korea
South Korea's first case of swine flu, resistant to the anti-viral drug Tamiflu, was reported by Health authorities on calling for extra precautions against any future cases.